Philips and University Hospital Brandenburg an der Havel Sign 10-Year Partnership to Advance Patient Care

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the University Hospital Brandenburg an der Havel (Brandenburg, Germany) have signed a 10-year strategic partnership to renew and expand the hospital's diagnostic and therapy options through the delivery of advanced technology solutions. The approximately EUR 18 million agreement includes the supply of diagnostic imaging solutions including ultrasound, MR and mobile X-ray, as well as image-guided therapy suites and patient monitoring solutions. The long-term cooperation will provide University Hospital Brandenburg an der Havel with optimum flexibility and a needs-based approach to technology selection and financing.

"We have decided to partner with Philips in order to ensure high-quality, economical medical care for the population of our region into the future," said Gabriele Wolter, Managing Director of University Hospital Brandenburg an der Havel. "Our joint activities will go well beyond device procurement and financing. There will be a uniform operating philosophy across devices and departments for renewal of our equipment inventory. In this way, we can speed up processes, minimize operating errors, and make its use easier throughout the clinic."

With around 500 beds, University Hospital Brandenburg an der Havel provides specialist care both locally and nationally for around 26,000 inpatients and 48,000 ambulatory patients in 15 specialized clinics. With medical excellence, innovative therapies and interdisciplinary teams, more than 2,000 employees work toward a common goal: ensuring first-class treatment quality by linking teaching, research and patient care.

Advanced diagnostic and therapy options, together with a modern standardized equipment inventory, are an important part of the hospital’s development for the future. A significant strategic element of the agreement with Philips is enhancement of the hospital's vascular and cardiology specialist services. This includes the upgrading of two existing interventional suites for cardiac and vascular procedures and installation of a new hybrid operating room equipped with Philips' Image-Guided Therapy System - Azurion - for minimally-invasive interventions. Minimally invasive techniques offer significant benefits for healthcare systems and patients, including reduced patient trauma (less patient risk), shorter recovery times and hospital stays (faster patient throughput), and lower health care costs.

"The aim of our cooperation is to take a holistic approach to the design and organization of healthcare along the full treatment pathways in the hospital, with our top priorities being improving outcomes, enhancing the patient and staff experience, and reducing the cost of care," said Heiko Borwieck, Health Systems Sales Leader, Philips Germany.

Well-trained medical and nursing staff are an important part of comprehensive patient care. Philips’ ICARUS learning academy for medical and technical staff will be integrated into the hospital's existing training and education program as part of the cooperation. Combining digital and face-to-face teaching methods, the platform will allow the hospital’s radiology team to be trained individually or in groups, independent of their location. The aim is to meet the daily challenges of the radiology workplace through the training of all employees so that the hospital can deliver a high-quality standard of care.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...